Prokidney Corp.
PROK- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850270
In the last 90 days, Prokidney Corp. insiders filed 0 open-market purchases and 1 sale; 71 institutions reported holding it in 13F filings for Q2 2026, worth $99.5M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Prokidney Corp. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 18 | 27 | +9 |
| Shares | 16.0M | 31.4M | +15.4M (+96.2%) |
| Value | $144.4M | $215.6M | +$71.3M (+49.4%) |
New holders (11)
Institutions that held Prokidney Corp. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Social Capital Group LLC | 13,273,000 | $91.1M | 77.68% |
| Brown University | 1,000,000 | $6.86M | 2.87% |
| Swiss National Bank | 74,301 | $509.7K | 0.00% |
| State Street Corp | 51,123 | $350.7K | 0.00% |
| State of Wisconsin Investment Board | 30,841 | $211.6K | 0.00% |
| California State Teachers Retirement System | 26,686 | $183.1K | 0.00% |
| Amundi | 23,822 | $182.2K | 0.00% |
| Goldman Sachs Group Inc | 15,722 | $107.9K | 0.00% |
| Legal & General Group Plc | 8,286 | $56.8K | 0.00% |
| JPMorgan Chase & Co | 3,367 | $23.0K | 0.00% |
| Citigroup Inc | 767 | $5.26K | 0.00% |
Sold out (2)
Institutions that held Prokidney Corp. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Moore Capital Management, LP | 26,500 | $239.0K |
| Verition Fund Management LLC | 14,603 | $132.0K |